155 related articles for article (PubMed ID: 37052871)
1. Valproic acid radiosensitizes anaplastic thyroid cells through a decrease of the DNA damage repair capacity.
Perona M; Ibañez IL; Thomasz L; Villaverde MS; Oglio R; Rosemblit C; Grissi C; Campos-Haedo M; Dagrosa MA; Cremaschi G; Durán HA; Juvenal GJ
J Endocrinol Invest; 2023 Nov; 46(11):2353-2365. PubMed ID: 37052871
[TBL] [Abstract][Full Text] [Related]
2. Radiosensitivity enhancement of human thyroid carcinoma cells by the inhibitors of histone deacetylase sodium butyrate and valproic acid.
Perona M; Thomasz L; Rossich L; Rodriguez C; Pisarev MA; Rosemblit C; Cremaschi GA; Dagrosa MA; Juvenal GJ
Mol Cell Endocrinol; 2018 Dec; 478():141-150. PubMed ID: 30125607
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells.
Catalano MG; Fortunati N; Pugliese M; Poli R; Bosco O; Mastrocola R; Aragno M; Boccuzzi G
J Endocrinol; 2006 Nov; 191(2):465-72. PubMed ID: 17088416
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of valproic acid in DNA double-strand break repair after irradiation in esophageal squamous carcinoma cells.
Makita N; Ninomiya I; Tsukada T; Okamoto K; Harada S; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Oyama K; Nakagawara H; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
Oncol Rep; 2015 Sep; 34(3):1185-92. PubMed ID: 26135807
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid.
Camphausen K; Cerna D; Scott T; Sproull M; Burgan WE; Cerra MA; Fine H; Tofilon PJ
Int J Cancer; 2005 Apr; 114(3):380-6. PubMed ID: 15578701
[TBL] [Abstract][Full Text] [Related]
6. Utility of a histone deacetylase inhibitor (PXD101) for thyroid cancer treatment.
Lin SF; Lin JD; Chou TC; Huang YY; Wong RJ
PLoS One; 2013; 8(10):e77684. PubMed ID: 24155971
[TBL] [Abstract][Full Text] [Related]
7. Effect of valproic acid on miRNAs affecting histone deacetylase in a model of anaplastic thyroid cancer.
Gunel NS; Birden N; Kurt CC; Bagca BG; Shademan B; Sogutlu F; Ozates NP; Avci CB
Mol Biol Rep; 2021 Aug; 48(8):6085-6091. PubMed ID: 34374891
[TBL] [Abstract][Full Text] [Related]
8. The heat shock protein 90 inhibitor SNX5422 has a synergistic activity with histone deacetylase inhibitors in induction of death of anaplastic thyroid carcinoma cells.
Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
Endocrine; 2016 Feb; 51(2):274-82. PubMed ID: 26219406
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of DNA ligase IV provides additional efficacy to the treatment of anaplastic thyroid cancer.
Sriramareddy SN; Jamakhani M; Vilanova L; Brossel H; Staumont B; Hamaidia M
Front Oncol; 2024; 14():1323313. PubMed ID: 38380364
[TBL] [Abstract][Full Text] [Related]
10. Postradiation sensitization of the histone deacetylase inhibitor valproic acid.
Chinnaiyan P; Cerna D; Burgan WE; Beam K; Williams ES; Camphausen K; Tofilon PJ
Clin Cancer Res; 2008 Sep; 14(17):5410-5. PubMed ID: 18765532
[TBL] [Abstract][Full Text] [Related]
11. Synergistic anticancer activity of sorafenib, paclitaxel, and radiation therapy on anaplastic thyroid cancer in vitro and in vivo.
Kim SY; Kim SM; Chang H; Chang HS; Park CS; Lee YS
Head Neck; 2020 Dec; 42(12):3678-3684. PubMed ID: 32896015
[TBL] [Abstract][Full Text] [Related]
12. Effect of valproic acid on radiation-induced DNA damage in euchromatic and heterochromatic compartments.
Harikrishnan KN; Karagiannis TC; Chow MZ; El-Osta A
Cell Cycle; 2008 Feb; 7(4):468-76. PubMed ID: 18239454
[TBL] [Abstract][Full Text] [Related]
13. Effects of nutraceuticals on anaplastic thyroid cancer cells.
Allegri L; Rosignolo F; Mio C; Filetti S; Baldan F; Damante G
J Cancer Res Clin Oncol; 2018 Feb; 144(2):285-294. PubMed ID: 29197967
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting BRAF Oncogene-Mediated Radioresistance Effectively Radiosensitizes BRAF
Robb R; Yang L; Shen C; Wolfe AR; Webb A; Zhang X; Vedaie M; Saji M; Jhiang S; Ringel MD; Williams TM
Clin Cancer Res; 2019 Aug; 25(15):4749-4760. PubMed ID: 31097454
[TBL] [Abstract][Full Text] [Related]
15. Histone Deacetylase Inhibitors and Anaplastic Thyroid Carcinoma.
Spartalis E; Athanasiadis DI; Chrysikos D; Spartalis M; Boutzios G; Schizas D; Garmpis N; Damaskos C; Paschou SA; Ioannidis A; Tsourouflis G; Dimitroulis D; Nikiteas NI
Anticancer Res; 2019 Mar; 39(3):1119-1127. PubMed ID: 30842140
[TBL] [Abstract][Full Text] [Related]
16. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ
Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531
[TBL] [Abstract][Full Text] [Related]
17. Effect of valproic acid, a histone deacetylase inhibitor, on cell death and molecular changes caused by low-dose irradiation.
Záskodová D; Rezácová M; Vávrová J; Vokurková D; Tichy A
Ann N Y Acad Sci; 2006 Dec; 1091():385-98. PubMed ID: 17341630
[TBL] [Abstract][Full Text] [Related]
18. In vitro studies of DNA damage and repair mechanisms induced by BNCT in a poorly differentiated thyroid carcinoma cell line.
Rodriguez C; Carpano M; Curotto P; Thorp S; Casal M; Juvenal G; Pisarev M; Dagrosa MA
Radiat Environ Biophys; 2018 May; 57(2):143-152. PubMed ID: 29453554
[TBL] [Abstract][Full Text] [Related]
19. Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis.
Sadowski SM; Boufraqech M; Zhang L; Mehta A; Kapur P; Zhang Y; Li Z; Shen M; Kebebew E
Oncotarget; 2015 Jul; 6(20):18038-49. PubMed ID: 25945839
[TBL] [Abstract][Full Text] [Related]
20. Valproic acid decreases the reparation capacity of irradiated MOLT-4 cells.
Muthna D; Vavrova J; Lukasova E; Tichy A; Knizek J; Kohlerova R; Mazankova N; Rezacova M
Mol Biol (Mosk); 2012; 46(1):122-8. PubMed ID: 22642109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]